Scan to Download
One power score. Smarter investment decisions
Beta Bionics Inc
BBNX28.820USD
+1.330+4.84%
Close 11/11, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 11/12, 09:30 (ET)
1.27BMarket Cap
LossP/E TTM
Beta Bionics Inc
28.820
+1.330+4.84%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
Total revenue
63.14%27.25M
54.45%23.24M
36.39%17.64M
144.79%20.44M
440.09%16.70M
2625.72%15.05M
--12.93M
--8.35M
--3.09M
--552.00K
--0.00
Revenue
63.14%27.25M
54.45%23.24M
36.39%17.64M
144.79%20.44M
440.09%16.70M
2625.72%15.05M
--12.93M
--8.35M
--3.09M
--552.00K
--0.00
Cost of revenue
55.74%12.13M
54.19%10.73M
51.22%8.67M
166.15%8.75M
317.08%7.79M
1211.11%6.96M
--5.73M
--3.29M
--1.87M
--531.00K
--0.00
Operating expenses
60.02%44.30M
60.68%43.11M
62.07%36.28M
100.26%33.48M
133.11%27.68M
180.44%26.83M
131.12%22.39M
--16.72M
--11.88M
--9.57M
--9.69M
R&D expenses
59.40%8.20M
39.73%8.87M
38.53%7.59M
106.59%9.21M
33.39%5.14M
68.79%6.35M
-6.61%5.48M
--4.46M
--3.85M
--3.76M
--5.87M
Depreciation, depletion, and amortization
15.92%386.00K
16.05%347.00K
110.45%604.00K
-2.76%529.00K
11.74%333.00K
-3.86%299.00K
-11.69%287.00K
--544.00K
--298.00K
--311.00K
--325.00K
Other operating expenses
----
----
----
---4.96M
----
----
----
----
----
----
--1.94M
Operating profit
-55.26%-17.04M
-68.64%-19.87M
-97.21%-18.64M
-55.81%-13.04M
-24.99%-10.98M
-30.72%-11.78M
2.41%-9.45M
---8.37M
---8.78M
---9.02M
---9.69M
Net non-operating interest income (expenses)
Non-operating interest income
243.10%2.83M
202.62%3.00M
113.12%2.44M
-23.98%951.00K
110.18%826.00K
1360.29%993.00K
1658.46%1.14M
--1.25M
--393.00K
--68.00K
--65.00K
Non-operating interest expense
----
0.00%2.00K
----
----
--4.00K
-84.62%2.00K
----
--55.00K
----
--13.00K
----
Special income (expenses)
-100.00%0.00
100.00%0.00
-200.80%-12.45M
48.43%-6.02M
243.99%419.00K
-282.59%-3.67M
---4.14M
---11.68M
---291.00K
--2.01M
--0.00
Income before tax
---14.21M
---16.87M
---28.66M
3.93%-18.11M
----
----
----
---18.85M
----
----
----
Income after tax
---14.21M
---16.87M
---28.66M
3.93%-18.11M
----
----
----
---18.85M
----
----
----
Net income from continuous operations
-45.94%-14.21M
-16.64%-16.87M
-130.19%-28.66M
3.93%-18.11M
-12.17%-9.74M
-108.10%-14.46M
-29.39%-12.45M
---18.85M
---8.68M
---6.95M
---9.62M
Net Income attributable to non-controlling interests
----
----
----
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
Net income attributable to controlling interests
-45.94%-14.21M
-16.64%-16.87M
-130.19%-28.66M
3.93%-18.11M
-12.17%-9.74M
-108.10%-14.46M
-29.39%-12.45M
---18.85M
---8.68M
---6.95M
---9.62M
Net income attributable to common shareholders
-45.94%-14.21M
-16.64%-16.87M
-130.19%-28.66M
3.93%-18.11M
-12.17%-9.74M
-108.10%-14.46M
-29.39%-12.45M
---18.85M
---8.68M
---6.95M
---9.62M
Basic earnings per share
-43.35%-0.33
-15.21%-0.39
-221.20%-0.93
3.92%-0.42
-12.17%-0.23
-108.10%-0.34
-29.39%-0.29
---0.44
---0.20
---0.16
---0.22
Diluted earnings per share
-43.35%-0.33
-15.21%-0.39
-221.20%-0.93
3.92%-0.42
-12.17%-0.23
-108.10%-0.34
-29.39%-0.29
---0.44
---0.20
---0.16
---0.22
Dividend per share
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
